50 mg Nitroglycerin in 5% Dextrose Injection (200 mcg/mL), 250 mL glass containers, Baxter Healthcare Corp., Deerfield, IL --- NDC 0338-1049-02
Published February 12, 2014 · Recall initiated: November 18, 2013
Summary
FDA records drug Class I recall D-1057-2014, published February 12, 2014 and initiated November 18, 2013. Recalling firm: Baxter Healthcare Corp.; Status: Terminated; Reported quantity: 49,932 glass containers; Lot: G105197, Exp. 02/14. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter; particulate matter in one vial identified as silicone rubber and EPDM rubber from the vial stopper.
What to do
Voluntary: Firm initiated · Letter
Get an email if NITROGLYCERIN IN DEXTROSE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- NITROGLYCERIN IN DEXTROSE
- Manufacturer
- Baxter Healthcare Corp.
- Distributor
- Nationwide, Saudi Arabia and Colombia
- Lot
- G105197, Exp. 02/14
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACornea Coat, Hydroxypropylmethylcellulose, 1.5ml Syringe, Rx Only. Manufactured by: Insight Instruments, Inc.,February 12, 2014
- FDAGlucotrol XL (glipizide) extended release tablets, 5 mg, 100 count bottles, Rx only, Distributed by Roerig,February 12, 2014
- FDADicopanol FusePaq Kit for Oral Suspension, 5mg/MLFebruary 12, 2014
- FDAGlipizide XL (glipizide) extended release tablets, 5 mg , 500 count bottles, Rx only, Distributed by:February 12, 2014
- FDACefepime for Injection USP and Dextrose Injection USP, in Duplex Drug Delivery System, 1 g in 50 mL duplexFebruary 12, 2014
- FDADiclofenac Sodium and Misoprostol Delayed-Release Tablets, 75mg/0.2mg, Rx only, Manufactured by WatsonFebruary 12, 2014
Questions about this recall
Was 50 mg Nitroglycerin in 5% Dextrose Injection (200 mcg/mL), 250 mL glass containers, Baxter Healthcare Corp., Deerfield, IL --- NDC 0338-1049-02 recalled?
Yes. FDA published recall D-1057-2014 on February 12, 2014. Reported hazard: Presence of Particulate Matter; particulate matter in one vial identified as silicone rubber and EPDM rubber from the vial stopper.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: NITROGLYCERIN IN DEXTROSE.